<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
EXHIBIT 27.1   FINANCIAL DATA SCHEDULE

This schedule contains summary financial information extracted from the interim
condensed consolidated financial statements of Dental/Medical Diagnostic
Systems, Inc. as of and for the nine-month period ended September 30, 2000
included in this report on Form 10-QSB and is qualified in its entirety by
reference to such financial statements.

</LEGEND>
<CURRENCY>                                  U.S. DOLLARS

<S>                                         <C>
<PERIOD-TYPE>                               3-MOS
<FISCAL-YEAR-END>                                              DEC-31-2000
<PERIOD-START>                                                  JAN-1-2000
<PERIOD-END>                                                   SEP-30-2000
<EXCHANGE-RATE>                                                     1.4787
<CASH>                                                             561,267
<SECURITIES>                                                             0
<RECEIVABLES>                                                    1,764,060
<ALLOWANCES>                                                       471,826
<INVENTORY>                                                      5,933,019
<CURRENT-ASSETS>                                                10,329,391
<PP&E>                                                           2,668,019
<DEPRECIATION>                                                   1,148,892
<TOTAL-ASSETS>                                                  14,009,216
<CURRENT-LIABILITIES>                                           10,050,556
<BONDS>                                                                  0
<PREFERRED-MANDATORY>                                            4,216,330
<PREFERRED>                                                              0
<COMMON>                                                           126,149
<OTHER-SE>                                                       (483,073)
<TOTAL-LIABILITY-AND-EQUITY>                                    14,009,216
<SALES>                                                         16,996,800
<TOTAL-REVENUES>                                                16,996,800
<CGS>                                                           12,679,225
<TOTAL-COSTS>                                                   15,234,547
<OTHER-EXPENSES>                                                  (69,911)
<LOSS-PROVISION>                                                         0
<INTEREST-EXPENSE>                                                 255,755
<INCOME-PRETAX>                                               (11,147,339)
<INCOME-TAX>                                                      (46,843)
<INCOME-CONTINUING>                                           (11,100,496)
<DISCONTINUED>                                                           0
<EXTRAORDINARY>                                                          0
<CHANGES>                                                                0
<NET-INCOME>                                                  (11,100,496)
<EPS-BASIC>                                                         (1.88)
<EPS-DILUTED>                                                       (1.88)


</TABLE>